What's next in the saga of Mylan, the fentanyl patch manufacturer whose employees allegedly bypassed quality controls?
NEW YORK, July 29 (Reuters) – Mylan (MYL.O), the world's No. 3 generic drugmaker, said on Wednesday that it had reshuffled its management after a report on its quality controls sparked volatility in its share price.
Heather Bresch, formerly chief operating officer, is being promoted to the position of president, and Rajiv Malik will take on the role of chief operating officer, the company said. Most recently, Malik headed global technical operations, overseeing quality and regulatory affairs, among other areas.
Not sure what to make of the fact that the individual who was chagred with "overseeing quality and regulatory affairs" got a promotion out of this… but then again, the allegations are that employees hid defects from the quality control department.